Dimensional Fund Advisors LP Aeglea Bio Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.5 - $2.66 $87,319 - $464,537	-174,638 Reduced 25.65%	506,326 $255,000
Q1 2022 May 13, 2022	SELL	$1.87 - $4.77 $17,968 - $45,834	-9,609 Reduced 1.39%	680,964 $1.57 Million
Q4 2021 Feb 09, 2022	BUY	$3.5 - $8.42 $202,090 - $486,170	57,740 Added 9.12%	690,573 $3.28 Million
Q3 2021 Nov 12, 2021	BUY	$6.03 - $7.95 $173,187 - $228,331	28,721 Added 4.75%	632,833 $5.03 Million
Q2 2021 Aug 12, 2021	BUY	$6.32 - $8.38 $67,592 - $89,624	10,695 Added 1.8%	604,112 $4.21 Million
Q1 2021 May 14, 2021	BUY	$6.76 - $8.57 $360,815 - $457,423	53,375 Added 9.88%	593,417 $4.69 Million
Q4 2020 Feb 25, 2021	BUY	$7.02 - $9.83 $3.79 Million - $5.31 Million	540,042 New	540,042 $4.25 Million

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.